Learn more at LeadIQ.com

Insights

Cell Therapy Leadership AlloVir is a leader in developing cell therapies focused on restoring natural immunity against life-threatening virus-associated diseases, presenting significant sales opportunities in the biotechnology research sector.

Technological Advancements AlloVir utilizes advanced technology platforms in its manufacturing processes, indicating potential partnerships for technology providers keen on supporting innovative biotechnology research companies.

Legal Challenges Impact Legal challenges faced by AlloVir present an opportunity for law firms specializing in securities, class action lawsuits, and business practices to offer services to the company and similar entities.

Financial Soundness With significant funding and a revenue range of $10M - $50M, AlloVir's stable financial position provides avenues for financial service providers seeking to engage with successful biotech companies.

Market Differentiation AlloVir's unique approach to treating multiple viruses with single allogeneic cell therapy sets them apart in the market, creating potential interest from investors looking for innovative biotech firms.

Similar companies to AlloVir

AlloVir Tech Stack

AlloVir uses 8 technology products and services including Google Analytics, jsDelivr, MySQL, and more. Explore AlloVir's tech stack below.

Google Analytics
Analytics
jsDelivr
Content Delivery Network
MySQL
Database
Google Font API
Font Scripts
Typekit
Font Scripts
JSON
Programming Languages
Smartsheet
Project Management
reCAPTCHA
Security

Media & News

AlloVir's Email Address Formats

AlloVir uses at least 1 format(s):

AlloVir Email Formats	Example	Percentage
FLast@allovir.com	JDoe@allovir.com	97%
FL@allovir.com	JD@allovir.com	1%
FMLast@allovir.com	JMDoe@allovir.com	1%
First.Last@allovir.com	John.Doe@allovir.com	1%

Frequently Asked Questions

Where is AlloVir's headquarters located?

AlloVir's main headquarters is located at 1100 Winter Street Waltham, MA 02451 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is AlloVir's stock symbol?

AlloVir is a publicly traded company; the company's stock symbol is ALVR.

What is AlloVir's official website and social media links?

AlloVir's official website is allovir.com and has social profiles on LinkedIn.

How much revenue does AlloVir generate?

As of September 2024, AlloVir's annual revenue reached $15M.

What is AlloVir's SIC code NAICS code?

AlloVir's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AlloVir have currently?

As of September 2024, AlloVir has approximately 51 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: D. B.Chief Product Development Officer: J. V.Head Regulatory Cmc, Allovir: F. M.. Explore AlloVir's employee directory with LeadIQ.

What industry does AlloVir belong to?

AlloVir operates in the Biotechnology Research industry.

What technology does AlloVir use?

AlloVir's tech stack includes Google AnalyticsjsDelivrMySQLGoogle Font APITypekitJSONSmartsheetreCAPTCHA.

What is AlloVir's email format?

AlloVir's email format typically follows the pattern of . Find more AlloVir email formats with LeadIQ.

How much funding has AlloVir raised to date?

As of September 2024, AlloVir has raised $75M in funding. The last funding round occurred on Jun 21, 2023 for $75M.

AlloVir

AlloVir

Biotechnology ResearchMassachusetts, United States51-200 Employees

AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVir’s technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.

Company Overview

Headquarters: 1100 Winter Street Waltham, MA 02451 US
Website: allovir.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ALVR
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 51-200

Media & News

Funding & Financials

$75M
AlloVir has raised a total of $75M of funding over 5 rounds. Their latest funding round was raised on Jun 21, 2023 in the amount of $75M.
$10M$50M
AlloVir's revenue is in the range of $10M$50M

Funding & Financials

$75M
AlloVir has raised a total of $75M of funding over 5 rounds. Their latest funding round was raised on Jun 21, 2023 in the amount of $75M.
$10M$50M
AlloVir's revenue is in the range of $10M$50M

Company Leadership

D. B.
Chief Executive Officer
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. V.
Chief Product Development Officer
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. M.
Head Regulatory Cmc, Allovir
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
I. H.
Head Of European Regulatory Affairs
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. G.
Head Of Quality Control
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

M. S.
Senior Vice President Business Development
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. D.
Senior Director, Head Of Commercial Strategy And Operations
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. B.
Vice President, Head Of It
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. M.
Head Regulatory Cmc, Allovir
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
I. H.
Head Of European Regulatory Affairs
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for AlloVir and Millions of Other Companies
Sign up for full access to AlloVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.